Sakari Hietanen

- Docent,
Faculty of Medicine (University of Turku)
- ,
Obstetrics and Gynaecology (Department of Clinical Medicine)

sakari.hietanen@utu.fi

Publications

7 of 8

Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study (2019)
- Cancer Imaging
Laasik M, Kemppainen J, Auranen A, Hietanen S, Grénman S, Seppänen M, Hynninen J
(A1 Refereed original research article in a scientific journal)
CtDNA profiling to predict prognosis and optimize treatment in high-grade serous ovarian cancer (2019)
- Clinical Cancer Research
Oikkonen J, Zhang KY, Salminen L, Huhtinen K, Schulman I, Andersson N, Carpen O, Hietanen S, Grenman S, Lehtonen R, Hynninen J, Farkkila A, Hautaniemi S
(Other publication)
Decorin Expression in Human Vulva Carcinoma: Oncosuppressive Effect of Decorin cDNA Transduction on Carcinoma Cells (2019)
- Journal of Histochemistry and Cytochemistry
Marie C. Nyman, Anne B. Jokilammi, Pia C. Boström, Samu H. Kurki, Annele O. Sainio, Seija E. Grenman, Katri J. Orte, Sakari H. Hietanen, Klaus Elenius, Hannu T. Järveläinen
(A1 Refereed original research article in a scientific journal)
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial (2019)
- Lancet Oncology
Mirza MR, Lundqvist EA, Birrer M, Christensen RD, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, Knudsen AO, Staff S, Vistisen AK, Bjorge L, Maenpaa JU
(A1 Refereed original research article in a scientific journal)
Open Source Infrastructure for Health Care Data Integration and Machine Learning Analyses (2019)
- JCO Clinical Cancer Informatics
Isoviita VM, Salminen L, Azar J, Lehtonen R, Roering P, Carpén O, Hietanen S, Grénman S, Hynninen J, Färkkilä A, Hautaniemi S
(A1 Refereed original research article in a scientific journal)
Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer (2019)
- JCO Precision Oncology
Oikkonen J, Zhang KY, Salminen L, Schulman I, Lavikka K, Andersson N, Ojanperä E, Hietanen S, Grenman S, Lehtonen R, Huhtinen K, Carpen O, Hynninen J, Färkkilä A, Hautaniemi S
(A1 Refereed original research article in a scientific journal)
Virtual clinical trials identify effective combination therapies in ovarian cancer (2019)
- Scientific Reports
Kozlowska E, Vallius T, Hynninen J, Hietanen S, Farkkila A, Hautaniemi S
(A1 Refereed original research article in a scientific journal)
Vulvar malignant pleomorphic adenoma in a patient with lichen sclerosus (2019)
- Journal of The American Academy of Dermatology
Niina Hieta, Samu Kurki, Marjut Rintala, Jenni Söderlund, Sakari Hietanen, Katri Orte
(B1 Non-refereed article in a scientific journal)
A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients (2018)
- Clinical Cancer Research
Tumiati M, Hietanen S, Hynninen J, Pietilä E, Färkkilä A, Kaipio K, Roering P, Huhtinen K, Alkodsi A, Li Y, Lehtonen R, Erkan EP, Tuominen MM, Lehti K, Hautaniemi SK, Grénman S, Vähärautio A, Carpén O, Kauppi L
(A1 Refereed original research article in a scientific journal)
Identifying differentially methylated sites in samples with varying tumor purity (2018)
- Bioinformatics
Antti Häkkinen, Amjad Alkodsi, Chiara Facciotto, Kaiyang Zhang, Katja Kaipio, Sirpa Leppä, Olli Carpén, Seija Grénman, Johanna Hynninen, Sakari Hietanen Rainer Lehtonen, Sampsa Hautaniemi
(A1 Refereed original research article in a scientific journal)